Encouraging clinical data for universal flu vaccine candidate
…with no adjuvant. Group 3: Placebo Control 1 Day 1: (i.n.) Saline solution. Day 85: (i.m.) PBS Group 4: IIV8/AS03-IIV5/AS03 Day 1: (i.m.) IIV vaccine expressing cH8/1N1 with AS03. Day…
…with no adjuvant. Group 3: Placebo Control 1 Day 1: (i.n.) Saline solution. Day 85: (i.m.) PBS Group 4: IIV8/AS03-IIV5/AS03 Day 1: (i.m.) IIV vaccine expressing cH8/1N1 with AS03. Day…
…be very informative to use VirScan to search for antibodies against viruses that are not known to infect humans. Other animal viruses, plant viruses, insect viruses: to which do a…
…A/California/07/2009, the 2009 pandemic H1N1 virus. One to two days later the ferrets developed fever, sneezing, coughing, and nasal discharge; both viruses induced similar clinical signs. Virus was shed in…
…(3) by inhalation of virus-laden aerosols. The contribution of each mode to overall transmission of influenza is not known. However, CDC recommendations to control influenza virus transmission in health care…
…that is needed. Most virologists carry out their work under BSL-2 containment, so if you are working on influenza virus, poliovirus, herpesvirus, and a host of other viruses, you are…
…different Zika virus isolates can infect brain cells when the virus is placed directly on these cells. We cannot make any conclusions about the ability of the virus to invade…